Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OSBP | P22059 | 4/20 | 0.69 |
| ▸ | RORC | P51449 | 3/20 | 0.69 |
| ▸ | USP2 | O75604 | 2/20 | 0.69 |
| ▸ | CYP46A1 | Q9Y6A2 | 2/20 | 0.69 |
| ▸ | OSBP2 | Q969R2 | 2/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.69 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.69 |
| ▸ | SRD5A1 | P18405 | 3/20 | 0.61 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.58 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.58 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.58 |
| ▸ | NPC1L1 | Q9UHC9 | 2/20 | 0.57 |
| ▸ | POLA1 | P09884 | 1/20 | 0.57 |
| ▸ | FNTA | P49354 | 1/20 | 0.56 |
| ▸ | FNTB | P49356 | 1/20 | 0.56 |
| ▸ | CRYAB | P02511 | 1/20 | 0.55 |
| ▸ | HMGCR | P04035 | 1/20 | 0.55 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.55 |
| ▸ | ITGAV | P06756 | 1/20 | 0.55 |
| ▸ | SREBF2 | Q12772 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL288702 | 1.00 | OSBP (0.69) | OSBPRORCUSP2CYP46A1OSBP2 | |
| SCHEMBL336003 | 1.00 | OSBP (0.69) | OSBPRORCUSP2CYP46A1OSBP2 | |
| SCHEMBL28750282 | 1.00 | OSBP (0.69) | OSBPRORCUSP2CYP46A1OSBP2 | |
| SCHEMBL289374 | 1.00 | OSBP (0.69) | OSBPRORCUSP2CYP46A1OSBP2 | |
| SCHEMBL1917363 | 1.00 | OSBP (0.69) | OSBPRORCUSP2CYP46A1OSBP2 | |
| SCHEMBL6390184 | 1.00 | OSBP (0.69) | OSBPRORCUSP2CYP46A1OSBP2 | |
| SCHEMBL6387159 | 1.00 | OSBP (0.69) | OSBPRORCUSP2CYP46A1OSBP2 | |
| SCHEMBL3350440 | 1.00 | OSBP (0.69) | OSBPRORCUSP2CYP46A1OSBP2 | |
| SCHEMBL336002 | 1.00 | OSBP (0.69) | OSBPRORCUSP2CYP46A1OSBP2 | |
| SCHEMBL26642855 | 1.00 | OSBP (0.69) | OSBPRORCUSP2CYP46A1OSBP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078086-A1 | VERSATILE BIODEGRADABLE MOLECULES AS NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260069540-A1 | GENE DELIVERY AGENTS | TIBA BIOTECH LLC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260014077-A1 | NOVEL METHODS TO ENHANCE GENE DELIVERY | TIBA BIOTECH LLC (US) | 2026-01-15 | — | — | US | disclosed |
| EP-4667511-A2 | DENDRITIC ARCHITECTURES AS NONVIRAL VECTORS IN GENE DELIVERY | Tiba Biotech LLC (US) | 2025-12-24 | — | — | EP | disclosed |
| US-12491262-B2 | Gene delivery agents | TIBA BIOTECH LLC (US) | 2025-12-09 | — | — | US | disclosed |
| US-20250354174-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2025-11-20 | — | — | US | disclosed |
| US-12410448-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TIBA BIOTECH LLC (US) | 2025-09-09 | — | — | US | disclosed |
| US-20250144233-A1 | NOVEL GENE DELIVERY AGENTS | TIBA BIOTECH LLC | 2025-05-08 | — | — | US | disclosed |
| WO-2025096681-A1 | NOVEL GENE DELIVERY AGENTS | TIBA BIOTECH LLC (US) | 2025-05-08 | — | — | WO | disclosed |
| US-20240207187-A1 | DENDRITIC ARCHITECTURES AS NONVIRAL VECTORS IN GENE DELIVERY | TIBA BIOTECH LLC (US) | 2024-06-27 | — | — | US | disclosed |
| EP-4313170-A1 | DENDRITIC ARCHITECTURES AS NONVIRAL VECTORS IN GENE DELIVERY | Tiba Biotech LLC (US) | 2024-02-07 | — | — | EP | disclosed |
| US-11859201-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TIBA BIOTECH LLC (US) | 2024-01-02 | — | — | US | disclosed |
| US-20230310645-A1 | NANOPARTICLE COMPOSITION FOR THE DELIVERY OF NUCLEIC ACID AGENTS | TIBA BIOTECH LLC (US) | 2023-10-05 | — | — | US | disclosed |
| US-20230149562-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | TIBA BIOTECH LLC (US) | 2023-05-18 | — | — | US | disclosed |
| US-20230100837-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2023-03-30 | — | — | US | disclosed |
| WO-2023022926-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2023-02-23 | — | — | WO | disclosed |
| EP-4132586-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | Tiba Biotech LLC (US) | 2023-02-15 | — | — | EP | disclosed |
| WO-2022212838-A1 | DENDRITIC ARCHITECTURES AS NONVIRAL VECTORS IN GENE DELIVERY | TIBA BIOTECH LLC (US) | 2022-10-06 | — | — | WO | disclosed |
| EP-3890715-A1 | THERAPEUTICS TARGETING MUTANT ADENOMATOUS POLYPOSIS COLI (APC) FOR THE TREATMENT OF CANCER | The Board Of Regents Of The University Of Texas System (US) | 2021-10-13 | — | — | EP | disclosed |
| WO-2020117972-A1 | THERAPEUTICS TARGETING MUTANT ADENOMATOUS POLYPOSIS COLI (APC) FOR THE TREATMENT OF CANCER | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2020-06-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240207187-A1 | DENDRITIC ARCHITECTURES AS NONVIRAL VECTORS IN GENE DELIVERY | TLR3, TLR9, TLR6 | OSBP 406/4885RORC 1514/4885USP2 3690/4885 |
| US-12491262-B2 | Gene delivery agents | TSG101, TLR3, TLR9 | OSBP 1539/4885RORC 2282/4885USP2 2366/4885 |
| US-20250354174-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TLR9, TLR3, TSG101 | OSBP 3402/4885RORC 1597/4885USP2 3167/4885 |
| US-20260069540-A1 | GENE DELIVERY AGENTS | LIPC, L3MBTL1, L3MBTL3 | OSBP 833/4885RORC 2445/4885USP2 1837/4885 |
| US-20230100837-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TLR9, TLR3, TSG101 | OSBP 3402/4885RORC 1597/4885USP2 3167/4885 |
| US-20250144233-A1 | NOVEL GENE DELIVERY AGENTS | TSG101, STING1, TLR3 | OSBP 1594/4885RORC 2260/4885USP2 2342/4885 |
| US-20230149562-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | POLN, TLR9, TSG101 | OSBP 3888/4885RORC 1994/4885USP2 3009/4885 |
| US-12410448-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TLR9, TLR3, TSG101 | OSBP 3402/4885RORC 1597/4885USP2 3167/4885 |
| US-11859201-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TLR9, TLR3, TSG101 | OSBP 3402/4885RORC 1597/4885USP2 3167/4885 |
| US-20260014077-A1 | NOVEL METHODS TO ENHANCE GENE DELIVERY | LDLR, NPC1L1, LIPG | OSBP 1252/4885RORC 754/4885USP2 2582/4885 |
| US-20260078086-A1 | VERSATILE BIODEGRADABLE MOLECULES AS NUCLEIC ACID CARRIERS | NSUN2, SMC1A, SSU72 | OSBP 267/4885RORC 4796/4885USP2 1427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.